Dergiler / Medicine Science / 2017 / Cilt: 6 - Sayı: 2

Validity of systemic inflammatory response syndrome (SIRS) criteria, interleukin-6 and (MELD) score as prognostic tools in cirrhotic patients with acute renal failure admitted to Emergency Department in Suez Canal University Hospital, Egypt

Sayfa
319–327
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Value of IL-6>36.5 pg/ml has sensitivity of 83.3%, specificity of 80%, SIRS score>2 has sensitivity of 47.62%, specificity of 93.33%, in prediction of overall mortality among cirrhotic patients with acute renal failure, Value of MELD score>28 has sensitivity of 80.95%, specificity of 80%, in prediction of overall mortality among cirrhotic patients with acute renal failure

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Systemic inflammatory response syndrome (SIRS) is the body's response to an infectious or noninfectious insult.
📊
Temel Bulgular & Veri:Renal failure following sepsis has been observed in 1 third of patients with cirrhosis and ascites the prognosis for patients with cirrhosis and renal failure is poor: Acute kidney injury (AKI), is a relatively frequent problem, occurring in approximately 20% of hospitalized patients with cirrhosis.
💡
Sonuç & Katkı:Value of IL-6>36.5 pg/ml has sensitivity of 83.3%, specificity of 80%, SIRS score>2 has sensitivity of 47.62%, specificity of 93.33%, in prediction of overall mortality among cirrhotic patients with acute renal failure, Value of MELD score>28 has sensitivity of 80.95%, specificity of 80%, in prediction of overall mortality among cirrhotic patients with acute renal failure
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Systemic inflammatory response syndrome (SIRS) is the body's response to an infectious or noninfectious insult. Cirrhotic patients are predisposed to infection due to an impaired immune function acute kidney injury (AKI), is a frequent problem, in cirrhotic patients. Renal failure following sepsis has been observed in 1 third of patients with cirrhosis and ascites the prognosis for patients with cirrhosis and renal failure is poor: Acute kidney injury (AKI), is a relatively frequent problem, occurring in approximately 20% of hospitalized patients with cirrhosis. The prognosis for patients with cirrhosis and renal failure is poor, this extremely poor outcome is probably related to the combination of liver and renal failure, as well as to associated complications.To evaluate the outcome of the acute kidney injury in cirrhotic patients by using SIRS, IL-6 and value of MELD score in order to early diagnosis and treatment to improve outcome and to decrease short term mortality.as prognostic tools. Cross sectional observational study with prospective data collection. Data collected from 72 cirrhotic patients with acute kidney injury. All patients were followed up for 3 months and outcome was recorded. The 3 months mortality was 58.33%. 59.7% of the patients express SIRS criteria on admission to Emergency Department. SIRS criteria were significantly correlated with both ER mortality and 3 month mortality, serum level of IL-6 was 157.53 ± 191.59 pg/ml, there was significant relation between ER mortality, overall mortality and presence of infection and IL-6 levels. The mean MELD score was 30.32 ± 5.01, and Expected 3 month mortality according to MELD score ranged between "6% - 71.3%". There was significant relation between ER and overall mortality and MELD score. Value of IL-6>36.5 pg/ml has sensitivity of 83.3%, specificity of 80%, SIRS score>2 has sensitivity of 47.62%, specificity of 93.33%, in prediction of overall mortality among cirrhotic patients with acute renal failure, Value of MELD score>28 has sensitivity of 80.95%, specificity of 80%, in prediction of overall mortality among cirrhotic patients with acute renal failure

🔖

Bu Makaleye Atıf Yap

ELBAİH1, A. H. (2017). Validity of systemic inflammatory response syndrome (SIRS) criteria, interleukin-6 and (MELD) score as prognostic tools in cirrhotic patients with acute renal failure admitted to Emergency Department in Suez Canal University Hospital, Egypt. Medicine Science, Cilt: 6 - Sayı: 2, 319–327. https://ajindex.com/articles/277362

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Tsao GG, Parikh CR, Viola A. Acute kidney Injury in Cirhosis. Hepatology. 2008;48(6):2064-77
  2. Cardenas A, Gines P, Uriz J, Bessa X, Salmeron JM, Mas A. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors and short-term prognosis. Hepatology. 2001;34(4):671-6
  3. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology. 2003;37(2):233-43
  4. Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, NguyenKhac E, Lebrec D, Poynard T, Moreau R. Model for end-stage liverdisease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46(6):1872–82
  5. Gines P, Schrier RW. Renal failure in cirrhosis. N Eng J Med. 2009;361(13):1279-90
  6. Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, Salinas F, Donà S, Fagiuoli S, Sticca A, Zanus G, Cillo U, Frasson I, Destro C, Gatta A. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology. 2007;45(1):223–9
  7. Fang JT, Tasi MH, Tian YC, Jenq CC, Lin CY, Chen YC, Lien JM, Chen PC, Yang CW. Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure, Nephrol Dial Transplant. 2008;23(6):1961-9
  8. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jimenez W, Arroyo V, Rodes J, Gines P. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation, Hepatology, 2005;41(6):1282-9
  9. Kamath PS, Kim WR. The model for end stage liver disease (MELD). Hepatology. 2007;45(3):797-805
  10. Mackelaite L, Alasaukas ZC, Ranganna K. Renal failure in patients with cirrhosis. Med Clin N Am. 2009;93(4):855-69
  11. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, RoudotThoraval F. The burden of liver disease in Europe, a review of available epidemiological data. J Hepatol. 2013;58(3):593-608 12. Rocco JR, Soares M. Outcome of patients with cirrhosis admitted to intensve care unit. Rev Bras Ter Intensiva. 2010;22(1):11-8
  12. Choi YJ, Kim JH, Koo JK, Lee CI, Lee JY, Yang JH, Ko SY, Choe WH, Kwon SY, and Lee CH. Prevelance of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol. 2014;20(2):185-91
  13. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R. MELD scoring syste